CTLT – catalent, inc. (US:NASDAQ)
Stock Stats
News
Sarepta cut to Neutral at Citi on risks to valuation [Seeking Alpha]
Actym Therapeutics Expands Management Team with Key Appointments to Build Product Pipeline and Advance Clinical Development Strategies [Yahoo! Finance]
Beyond Elevidys: Unveiling The Competitive Landscape Of Duchenne's Muscular Dystrophy [Seeking Alpha]
Novo Nordisk plots $4.1 billion in U.S. factory amid Ozempic shortage, the same day it pulled out of its Ireland development project [Fortune]
Catalent, Inc. (NYSE: CTLT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Form 4 Catalent, Inc. For: Jun 04 Filed by: Hopson Ricky
Form 144 Catalent, Inc. Filed by: Hopson Ricky
Form 8-K Catalent, Inc. For: May 29
Form DEFA14A Catalent, Inc.
Form 8-K Catalent, Inc. For: May 16
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.